🧬 Twist Bioscience beats in Q4 — sales jump 28%
Twist Bioscience (TWST) reported fiscal Q4 revenue of $126.6 million, up 28% year over year and above estimates of $123.5 million. Its loss narrowed to $0.32 per share, beating expectations for a $0.39 loss, with positive adjusted EBITDA of $2.2 million.
Full-year revenue reached $459.4 million, up 22%, and the company guided fiscal 2027 revenue to $550–$560 million.
#TwistBioscience #TWST #Biotech #Earnings #Stocks #WallStreet
Twist Bioscience (TWST) reported fiscal Q4 revenue of $126.6 million, up 28% year over year and above estimates of $123.5 million. Its loss narrowed to $0.32 per share, beating expectations for a $0.39 loss, with positive adjusted EBITDA of $2.2 million.
Full-year revenue reached $459.4 million, up 22%, and the company guided fiscal 2027 revenue to $550–$560 million.
#TwistBioscience #TWST #Biotech #Earnings #Stocks #WallStreet
110 Views